Immunoadjunctive Therapy against Bacterial Infections Using Herbal Medicines Based on Th17 Cell-mediated Protective Immunity.

Current Pharmaceutical Design
Haruaki TomiokaChiaki Sano

Abstract

One of the major health concerns in the world is the global increase in intractable bacterial infectious diseases due to the emergence of multi- and extensively drug-resistant bacterial pathogens as well as increase in compromised hosts around the world. Particularly, in the case of mycobacteriosis, the high incidence of tuberculosis in developing countries, resurgence of tuberculosis in industrialized countries, and increase in the prevalence of Mycobacterium avium complex infections are important worldwide health concerns. However, the development of novel antimycobacterial drugs is currently making slow progress. Therefore, it is considered that devising improved administration protocols for clinical treatment against refractory mycobacteriosis using existing chemotherapeutics is more practical than awaiting the development of new antimycobacterial drugs. The regulation of host immune responses using immunoadjunctive agents may increase the efficacy of antimicrobial treatment against mycobacteriosis. The same situations also exist in cases of intractable infectious diseases due to common bacteria other than mycobacteria. The mild and long-term up-regulation of host immune reactions in hosts with intractable chronic bacterial...Continue Reading

References

Jun 8, 2002·Current Pharmaceutical Design·Ovanes Mekenyan
Nov 17, 2004·Current Pharmaceutical Design·Haruaki Tomioka
Sep 5, 2006·Bioorganic & Medicinal Chemistry·Marilia S CostaVitor F Ferreira
Sep 20, 2006·The Journal of Experimental Medicine·Spencer C LiangLynette A Fouser
Sep 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Euan LockhartJoAnne L Flynn
Mar 7, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masayuki UmemuraGoro Matsuzaki
Jul 12, 2007·Proceedings of the National Academy of Sciences of the United States of America·Akihiro KimuraTadamitsu Kishimoto
Jan 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thomas J ScribaWillem A Hanekom
Mar 7, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nural N OrgunSing Sing Way
May 21, 2008·The Journal of Experimental Medicine·Carol Ho Yan FongToby Lawrence
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marie BenoitJean-Louis Mege
Dec 17, 2008·Biochemical Pharmacology·Francesco MaioneFulvio D'Acquisto
Jan 8, 2009·Immunology·Meredith M Curtis, Sing Sing Way
Jan 9, 2009·European Journal of Immunology·Veronica SantarlasciFrancesco Annunziato
Mar 14, 2009·European Journal of Immunology·Francesco AnnunziatoSergio Romagnani
Mar 24, 2009·International Immunopharmacology·Andrea ChiccaJürg Gertsch
Jun 11, 2009·The Journal of Clinical Investigation·Zhe ZhangJeffrey N Weiser
Jul 22, 2009·The Journal of Clinical Investigation·Maira G R PittaAlain Dessein
Oct 9, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hong BaiXi Yang
Nov 6, 2009·Blood·Martin PelletierMarco A Cassatella
Sep 28, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Spencer C LiangLynette A Fouser
Oct 20, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sheng XuXuetao Cao
Jan 18, 2011·Nature Immunology·Thomas KrausgruberIrina A Udalova
Feb 16, 2011·Cell Host & Microbe·Kristin L MoffittRichard Malley
Feb 26, 2011·Immunity·Yoichiro IwakuraSusumu Nakae
Oct 15, 2011·Nature Reviews. Immunology·Peter J Murray, Thomas A Wynn
Nov 22, 2011·European Journal of Immunology·Radha GopalShabaana A Khader
Dec 27, 2011·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Kristen E Graeber, Nancy J Olsen
Mar 30, 2012·The Journal of Infectious Diseases·Michael UhlinMarkus Maeurer
Jun 23, 2012·American Journal of Respiratory and Critical Care Medicine·Weihui WuGregory P Priebe
Sep 11, 2012·Nature Immunology·Youjin LeeVijay K Kuchroo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.